Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 09:29 am Purchase |
2022-01-06 | 13D | Radius Recycling, Inc. RDUS |
BB Biotech AG | 8,255,714 17.400% |
800,000 (+10.73%) |
Filing History |
| 2021-09-15 6:23 pm Purchase |
2021-09-10 | 13G | Mersana Therapeutics, Inc. MRSN |
BB Biotech AG | 4,135,000 5.800% |
4,135,000 (New Position) |
Filing History |
| 2021-08-17 1:57 pm Purchase |
2021-08-16 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 4,765,814 10.800% |
2,780,000 (+139.99%) |
Filing History |
| 2021-08-11 5:04 pm Purchase |
2021-08-04 | 13G | Sage Therapeutics, Inc. SAGE |
BB Biotech AG | 2,960,104 5.000% |
2,960,104 (New Position) |
Filing History |
| 2021-06-11 5:25 pm Purchase |
2021-06-09 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 6,025,564 10.000% |
1,210,000 (+25.13%) |
Filing History |
| 2021-05-28 5:00 pm Purchase |
2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 4,477,964 15.900% |
530,000 (+13.42%) |
Filing History |
| 2021-05-27 4:33 pm Purchase |
2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 4,477,964 15.900% |
1,085,000 (+31.98%) |
Filing History |
| 2021-05-05 5:20 pm Purchase |
2021-04-29 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 1,985,814 5.100% |
1,985,814 (New Position) |
Filing History |
| 2021-04-26 1:11 pm Purchase |
2021-04-07 | 13G | Molecular Templates, Inc. MTEM |
BB Biotech AG | 636,175 17.000% |
210,819 (+49.56%) |
Filing History |
| 2021-02-12 5:18 pm Purchase |
2020-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
BB Biotech AG | 3,538,419 4.400% |
80,000 (+2.31%) |
Filing History |
| 2021-02-12 5:07 pm Purchase |
2020-12-31 | 13G | Molecular Templates, Inc. MTEM |
BB Biotech AG | 425,355 12.800% |
76,689 (+21.99%) |
Filing History |
| 2021-02-12 5:01 pm Sale |
2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BB Biotech AG | 3,970,000 2.900% |
-3,993,056 (-50.14%) |
Filing History |
| 2021-02-12 4:58 pm Purchase |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 3,947,964 14.200% |
220,000 (+5.90%) |
Filing History |
| 2021-02-12 4:54 pm Sale |
2020-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
BB Biotech AG | 2,255,651 6.700% |
-378,815 (-14.38%) |
Filing History |
| 2021-02-12 4:52 pm Purchase |
2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BB Biotech AG | 453,315 9.800% |
298,248 (+192.33%) |
Filing History |
| 2021-02-12 4:51 pm Unchanged |
2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BB Biotech AG | 2,680,283 7.200% |
0 (Unchanged) |
Filing History |
| 2021-02-12 4:48 pm Purchase |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB Biotech AG | 2,602,858 5.300% |
200,000 (+8.32%) |
Filing History |
| 2021-02-12 4:45 pm Sale |
2020-12-31 | 13G | Myovant Sciences Ltd. MYOV |
BB Biotech AG | 4,757,039 5.300% |
-58,070 (-1.21%) |
Filing History |
| 2021-02-12 4:40 pm Purchase |
2020-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 4,815,564 8.600% |
296,405 (+6.56%) |
Filing History |
| 2021-02-12 4:17 pm Purchase |
2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
BB Biotech AG | 141,125 6.400% |
26,361 (+22.97%) |
Filing History |